130 related articles for article (PubMed ID: 6190080)
1. Axonal transport in neuropathy.
Jakobsen J; Brimijoin S; Sidenius P
Muscle Nerve; 1983 Feb; 6(2):164-6. PubMed ID: 6190080
[TBL] [Abstract][Full Text] [Related]
2. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylacetylurea.
Nagata H; Brimijoin S
Ann Neurol; 1986 May; 19(5):458-64. PubMed ID: 2424360
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of axonal transport: are they a cause of peripheral nerve disease?
Brimijoin WS
Mayo Clin Proc; 1982 Nov; 57(11):707-14. PubMed ID: 6182427
[TBL] [Abstract][Full Text] [Related]
4. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
Sickles DW
Neurotoxicology; 1989; 10(1):91-101. PubMed ID: 2475836
[TBL] [Abstract][Full Text] [Related]
5. [Abnormalities of axonal transport as pathogenesis of axonal degeneration in peripheral neuropathy].
Nagata H
Rinsho Shinkeigaku; 1990 Dec; 30(12):1355-7. PubMed ID: 1966015
[TBL] [Abstract][Full Text] [Related]
6. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea.
Jakobsen J; Brimijoin S
Brain Res; 1981 Dec; 229(1):103-22. PubMed ID: 6171326
[TBL] [Abstract][Full Text] [Related]
7. Altered spectrum of retrogradely transported axonal proteins in p-bromophenylacetylurea neuropathy.
Oka N; Brimijoin S
Neurochem Res; 1993 Jun; 18(6):675-80. PubMed ID: 8389990
[TBL] [Abstract][Full Text] [Related]
8. [Impairment of rapid axonal transport and concomitant anomaly of smooth endoplasmic reticulum in acrylamide induced neuropathy].
Chrétien M; Souyri F; Patey G
C R Seances Acad Sci D; 1979 Feb; 288(7):689-92. PubMed ID: 88279
[TBL] [Abstract][Full Text] [Related]
9. Acrylamide neuropathy and changes in the axonal transport and muscular content of the molecular forms of acetylcholinesterase.
Couraud JY; Di Giamberardino L; Chretien M; Souyri F; Fardeau M
Muscle Nerve; 1982 Apr; 5(4):302-12. PubMed ID: 6178969
[TBL] [Abstract][Full Text] [Related]
10. Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea.
Brimijoin S; Mintz KP
Muscle Nerve; 1984; 7(9):725-32. PubMed ID: 6100457
[TBL] [Abstract][Full Text] [Related]
11. Early and dose-dependent decrease of retrograde axonal transport in acrylamide-intoxicated rats.
Jakobsen J; Sidenius P
J Neurochem; 1983 Feb; 40(2):447-54. PubMed ID: 6185637
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport.
Nagata H; Brimijoin S
Brain Res; 1986 Oct; 385(1):136-42. PubMed ID: 2429734
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: analysis by two-dimensional polyacrylamide gel electrophoresis.
Logan MJ; McLean WG
J Neurochem; 1988 Jan; 50(1):183-9. PubMed ID: 2447233
[TBL] [Abstract][Full Text] [Related]
14. Synaptophysin immunoreactive axonal swelling in p-bromophenylacetylurea-induced neuropathy.
Jortner BS; Dyer K; Walton A; Ehrich M
Neurotoxicology; 1997; 18(1):161-8. PubMed ID: 9215998
[TBL] [Abstract][Full Text] [Related]
15. Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography.
Oka N; Brimijoin WS
Mayo Clin Proc; 1992 Apr; 67(4):341-8. PubMed ID: 1372380
[TBL] [Abstract][Full Text] [Related]
16. Position sensitivity of de-efferented muscle spindles in experimental acrylamide neuropathy.
Lowndes HE; Baker T; Cho ES; Jortner BS
J Pharmacol Exp Ther; 1978 Apr; 205(1):40-8. PubMed ID: 204769
[TBL] [Abstract][Full Text] [Related]
17. Nervous system abnormality and nervous disease in diabetes.
Jakobsen J; Sidenius P; Lundbaek K
Acta Endocrinol Suppl (Copenh); 1980; 238():123-31. PubMed ID: 6159763
[TBL] [Abstract][Full Text] [Related]
18. Pathology of the peripheral neuropathy induced by p-bromophenylacetylurea.
Troncoso JC; Griffin JW; Price DL; Hess-Kozlow KM
Lab Invest; 1982 Feb; 46(2):215-23. PubMed ID: 7062723
[TBL] [Abstract][Full Text] [Related]
19. A proposal for a classification of neuropathies according to their axonal transport abnormalities.
Jakobsen J; Sidenius P; Braendgaard H
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):986-90. PubMed ID: 2428941
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
Lee PG; Hohman TC; Cai F; Regalia J; Helke CJ
Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
